Multiple-target effects of isoflavone derivative and its application in improvement of learning and memory
A technology for learning and memory impairment and function, which can be applied to medical preparations containing active ingredients, drug combinations, organic active ingredients, etc., and can solve the problem that single-target drugs are difficult to achieve ideal therapeutic effects.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0046] Example 1. Research on the up-regulation effect of J39136 on the expression of human SIRT1 gene at the cell level in vitro
[0047] Methods: The cell line stably transfected with human SIRT1 gene promoter reporter gene was used to express luciferase under drug stimulation, and the luciferase activity was expressed by the number related to light absorption (relative luminescence unit, RLU). Add 5 μl of screening samples (final concentration 10 μg / ml) to stably transfected cells in a 384-well plate, and after incubation for 24 hours, discard the drug-containing culture supernatant and add ONE-Glo TM Luciferase Assay System (Promega, U.S.A.) 10 μl of serum-free culture solution of the reaction reagent was shaken for 3 minutes, and M5 was used to detect the luminescence value. Up-regulation rate (%)=A / Bx100, wherein, A is the cell luciferase activity (RLU) measured after adding the sample to be tested, and B is the cell luciferase activity (RLU) measured after adding the bl...
Embodiment 2
[0049] Example 2. Study on the inhibitory effect of J39136 on the activity of ACHE and BuCHE at the molecular level in vitro
[0050] Methods: The AChE inhibitor screening model and the BuChE inhibitor screening model were established by DTNB method, the inhibitory activity of J39136 on AChE and BuChE was evaluated at 0.08-50 μmol / L, and the IC was calculated 50 . Repeat three times, calculate the mean and SD value.
[0051] Results: IC of J39136 inhibiting AChE and BuChE activities 50 All lower than 10μmol / L, IC for inhibiting BuChE activity 50 It is close to the positive control tetramethylisopropylpyrophosphate amine (iso-OMPA, a selective butyrylcholinesterase inhibitor), and far lower than the commercially available drug donepezil (a selective acetylcholinesterase inhibitor).
[0052] Table 1 IC of J39136 inhibiting ACHE / BuCHE activity 50
[0053]
Embodiment 3
[0054] Example 3, Research on the inhibitory effect of J39136 on AChE activity of nerve cells
[0055] Method 1: SY5Y cells are cultured in DMEM / F12 medium containing 10% fetal bovine serum. When the cells are in the logarithmic growth phase, press 5*10 4 Individuals / ml, 100ul / well density were inoculated in 96-well culture plate. After 24 hours, replace with serum-free DMEM / F12 medium for culture, and after 12 hours, replace with serum-free DMEM / F12 medium with different concentrations of J39136 (0.3-10 μmol / L), and treat with donepezil and Exelon (final concentration: 10 μmol / L) Similarly, after 24 hours, the cell viability was measured by the MTS method, and the AChE activity in the cell supernatant was detected by the DTNB method.
[0056] Results: Compared with the normal group, J39136 had no significant effect on the cell viability within the concentration range of administration, and the cell viability of the positive control group administered with donepezil was signi...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com